Insights into evolution and coexistence of the colibactin- and yersiniabactin secondary metabolite determinants in enterobacterial populations

Wami H, Wallenstein A, Sauer D, Stoll M, Bünau R, Oswald E, Müller R, Dobrindt U

Research article (journal) | Peer reviewed

Abstract

ABSTRACTThe bacterial genotoxin colibactin interferes with the eukaryotic cell cycle by causing dsDNA breaks. It has been linked to bacterially induced colorectal cancer in humans. Colibactin is encoded by a 54 kb genomic region inEnterobacteriaceae. The colibactin genes commonly co-occur with the yersiniabactin biosynthetic determinant. Investigating the prevalence and sequence diversity of the colibactin determinant and its linkage to the yersiniabactin operon in prokaryotic genomes, we discovered mainly species-specific lineages of the colibactin determinant and classified three main structural settings of the colibactin-yersiniabactin genomic region inEnterobacteriaceae. The colibactin gene cluster has a similar but not identical evolutionary track to that of the yersiniabactin operon. Both determinants could have been acquired on several occasions and/or exchanged independently between enterobacteria by horizontal gene transfer. Integrative and conjugative elements play(ed) a central role in the evolution and structural diversity of the colibactin-yersiniabactin genomic region. Addition of an activating and regulating module (clbAR) to the biosynthesis and transport module (clbB-S) represents the most recent step in the evolution of the colibactin determinant. In a first attempt to correlate colibactin expression with individual lineages of colibactin determinants and different bacterial genetic backgrounds, we compared colibactin expression of selected enterobacterial isolatesin vitro. Colibactin production in the testedKlebsiellaspecies andCitrobacter koseristrains was more homogeneous and generally higher than that in most of theEscherichia coliisolates studied. Our results improve the understanding of the diversity of colibactin determinants and its expression level, and may contribute to risk assessment of colibactin-producing enterobacteria.

Details about the publication

JournalMicrobial Genomics
Volume7
Issue6
StatusPublished
Release year2021 (15/06/2021)
Language in which the publication is writtenEnglish
DOI10.1099/mgen.0.000577
Link to the full texthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461471/pdf/mgen-7-0577.pdf
KeywordsCitrobacter; Escherichia coli; Klebsiella; cytopathic effect; high pathogenicity island; polyketide; secondary metabolite

Authors from the University of Münster

Dobrindt, Ulrich
Institute of Hygiene
Stoll, Monika
Humangenetik, Abt. für Genetische Epidemiologie
Wallenstein, Alexander
Institute of Hygiene
Wami, Haleluya Tesfaye
Institute of Hygiene